Papers ist eine fortschrittliche, KI-gestützte Literaturverwaltungssoftware für Studierende, Akademiker und Unternehmensforscher. Sie hilft Ihnen, Ihre Forschungsmaterialien zu organisieren, zu entdecken, zu analysieren und zu zitieren und optimiert so Ihren gesamten Arbeitsablauf von der Literaturrecherche bis zum Verfassen von Manuskripten.
Rayyan ist eine KI-gestützte Plattform, die für Forscher entwickelt wurde, um systematische Reviews und Literaturrecherchen zu beschleunigen. Sie optimiert den Prozess mit Funktionen wie automatisiertem Screening, Duplikaterkennung und Echtzeit-Kollaboration und spart Forschern bis zu 90 % ihrer Screening-Zeit. Über 800.000 Nutzer vertrauen darauf und es unterstützt den gesamten Review-Lebenszyklus vom Datenimport bis zum Abschlussbericht.
Papers ist eine fortschrittliche, KI-gestützte Literaturverwaltungssoftware für Studierende, Akademiker und Unternehmensforscher. Sie hilft Ihnen, Ihre Forschungsmaterialien zu organisieren, zu entdecken, zu analysieren und zu zitieren und optimiert so Ihren gesamten Arbeitsablauf von der Literaturrecherche bis zum Verfassen von Manuskripten.
Rayyan ist eine KI-gestützte Plattform, die für Forscher entwickelt wurde, um systematische Reviews und Literaturrecherchen zu beschleunigen. Sie optimiert den Prozess mit Funktionen wie automatisiertem Screening, Duplikaterkennung und Echtzeit-Kollaboration und spart Forschern bis zu 90 % ihrer Screening-Zeit. Über 800.000 Nutzer vertrauen darauf und es unterstützt den gesamten Review-Lebenszyklus vom Datenimport bis zum Abschlussbericht.
| Feature | Papers | Rayyan |
|---|---|---|
| Hauptkategorie | Akademisch | Akademisch |
| Hinzugefügt | 2025-09-13 | 2025-09-11 |
| Preismodell | Freemium | Freemium |
| Offizielle Website | papersapp.com | rayyan.ai |
| Produkttyp | Website | Website |
| Performance data | ||
| Nutzerbewertung | Nicht verifiziert | Nicht verifiziert |
| Kommentare | 0 | 0 |
| Monatliche Besuche | 65.8K | 1.1M |
| Monatliches Wachstum | 7.1% | -4% |
| Favoriten | 106 | 128 |
| Details | Details ansehen | Details ansehen |
Compare Papers and Rayyan by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
In the Papers vs Rayyan monthly traffic comparison, Papers currently shows 65.8K visits and Rayyan shows 1.1M; Rayyan has about 16.5 times the visible traffic of Papers, an absolute difference of about 1M visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 27.84% | 18.3K |
| 🇮🇶Iraq | 25.12% | 16.5K |
| 🇩🇪Germany | 16.33% | 10.7K |
| 🇧🇷Brazil | 15.76% | 10.4K |
| 🇮🇳India | 14.95% | 9.8K |
| Source type | Percentage | Traffic |
|---|---|---|
| Direkt | 79.53% | 52.3K |
| Verweis | 15.41% | 10.1K |
| 5.06% | 3.3K |
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 32.99% | 359.1K |
| 🇧🇷Brazil | 31.2% | 339.6K |
| 🇬🇧United Kingdom | 20.31% | 221K |
| 🇵🇰Pakistan | 7.75% | 84.3K |
| 🇵🇹Portugal | 7.75% | 84.3K |
| Source type | Percentage | Traffic |
|---|---|---|
| Direkt | 80.86% | 880.1K |
| Verweis | 14.66% | 159.6K |
| 4.48% | 48.8K |
This in-depth Papers vs Rayyan comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Papers is primarily listed under “Akademisch”, while Rayyan is primarily listed under “Akademisch”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Monthly visits (Papers: 65.8K; Rayyan: 1.1M); Monthly growth (Papers: 7.1%; Rayyan: -4%); Favorites (Papers: 106; Rayyan: 128); Website (Papers: papersapp.com; Rayyan: rayyan.ai); Added (Papers: 2025-09-13; Rayyan: 2025-09-11). These facts are more useful for selection than brand visibility alone.
In the Papers vs Rayyan monthly traffic comparison, Papers currently shows 65.8K visits and Rayyan shows 1.1M; Rayyan has about 16.5 times the visible traffic of Papers, an absolute difference of about 1M visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
If public market visibility is an important first-pass criterion, investigate Rayyan first. The final choice should still follow taxonomy, use case, and a real trial because higher traffic does not prove broader capabilities or better workflow fit.
Papers and Rayyan currently overlap in shared categories: Akademisch und Forschung; shared tags: Literaturübersicht; shared roles: Akademisch, Bibliothekar, Medizinisches Fachpersonal, Forscher und Wissenschaftler. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Papers's unique categories/tags are Zitation, Akademisches Schreiben, KI für Forschung, Bibliographie-Generator, Zitations-Tool, Kollaborationstool, Mendeley-Alternative und PDF-Anmerkung; Rayyan's are Akademisch, KI-Screening, Kollaboration, Datenanalyse, Deduplizierung, medizinische Forschung, Prisma und Forschung. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
Papers has no verified rating, 0 comments, 106 favorites, and 108 likes；Rayyan has no verified rating, 0 comments, 128 favorites, and 116 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Put Papers on the priority trial list when the task aligns with “Akademisch” and especially Zitation, Akademisches Schreiben, KI für Forschung, Bibliographie-Generator, Zitations-Tool und Kollaborationstool, or the users include Doktorand, F&E-Experte, Student und Autor. This follows recorded positioning and does not imply unlisted capabilities are absent.
Papers also currently records: pricing is freemium, product type is website, 65.8K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
Put Rayyan on the priority trial list when the task aligns with “Akademisch” and especially Akademisch, KI-Screening, Kollaboration, Datenanalyse, Deduplizierung und medizinische Forschung, or the users include Datenanalyst, Doktorand/in, Politikanalyst und Spezialist für öffentliche Gesundheit. This follows recorded positioning and does not imply unlisted capabilities are absent.
Rayyan also currently records: pricing is freemium, product type is website, 1.1M verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Papers and Rayyan, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
